Moberg Pharma AB

At a glance

Most recent filing on November 11, 2021 — an open-market purchase by Mark Beveridge on Nov 11, 2021.

We hold 7 visible filings, going back to December 9, 2019.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

Insider trades

5 of 7 shown

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings at this company, out of 7. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are the price history with every buy marked, the price change beside each line, and any moments with several buyers or buying streaks. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Mark Beveridge Chief financial officer
17,730 SEKOpen-market buy
TradedNov 11, 2021FiledNov 11, 2021
Mark Beveridge Chief financial officer
29,800 SEKOpen-market buy
TradedNov 9, 2021FiledNov 11, 2021
Mark Beveridge Chief financial officer
17,310 SEKOpen-market buy
TradedNov 10, 2021FiledNov 11, 2021
Cindy Wong Other member of the administrative, management or supervisory body
31,675 SEKOpen-market buy
TradedFeb 10, 2021FiledFeb 10, 2021
Cindy Wong Other member of the administrative, management or supervisory body
30,800 SEKOpen-market buy
TradedFeb 9, 2021FiledFeb 9, 2021